Clinical Trials on Endovascular Treatment in Japan
Total 31 results
-
BayerRecruiting
-
Osaka UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedAge Related Macular Degeneration | Neovascular MaculopathyJapan
-
BayerCompletedTreatment of Venous ThromboembolismJapan
-
Nagoya City UniversityNovartisCompletedNeovascular Age-related Macular DegenerationJapan
-
Alvotech Swiss AGActive, not recruitingNeovascular (Wet) AMDSlovakia, Czechia, Georgia, Japan, Latvia
-
BayerRegeneron PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedTreatment-Resistant DepressionSpain, Japan, Poland, United States
-
BayerRegeneron PharmaceuticalsCompletedGlaucoma, NeovascularJapan
-
Janssen Research & Development, LLCCompletedTreatment Resistant Depressive DisorderUnited States, Japan, Belgium
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Janssen Pharmaceutical K.K.Completed
-
Regeneron PharmaceuticalsTerminatedNeovascular Age-Related Macular DegenerationUnited States, Japan
-
Japanese Society for Early MobilizationRecruitingQuality of Life | Acute Respiratory Distress Syndrome | Treatment Compliance | Post Intensive Care SyndromeJapan
-
Kyowa Kirin, Inc.RecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States, Japan, Korea, Republic of, Australia
-
TakedaCompletedHormone Treatment-naïve Participants With Prostate CancerJapan
-
BayerRegeneron PharmaceuticalsCompletedNeovascular Macular DegenerationTaiwan, Hong Kong, Korea, Republic of, Japan, Singapore, Australia, Hungary, Germany
-
Samsung Bioepis Co., Ltd.CompletedNeovascular Age-related Macular DegenerationCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Poland, United States, Croatia, Japan, Russian Federation
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
H. Lundbeck A/STerminatedTreatment-resistant SchizophreniaUnited States, Japan, Russian Federation, Bulgaria, United Kingdom
-
Bioeq GmbHCompletedNeovascular Age-related Macular DegenerationBulgaria, Italy, Poland, Russian Federation, Hungary, Ukraine, Japan, Israel, Czechia
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationJapan
-
BayerTerminatedMacular DegenerationHong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Sam Chun Dang Pharm. Co. Ltd.CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States, Australia, Bulgaria, Czechia, Hungary, India, Israel, Japan, Korea, Republic of, Latvia, Poland, Russian Federation, Slovakia, Spain
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Hoffmann-La RocheRecruitingDiabetic Macular Edema | Neovascular Age-related Macular DegenerationGermany, Croatia, Japan, United Kingdom, Spain, United States, Italy, Switzerland, Canada, France, Australia, Singapore, Israel, Puerto Rico, United Arab Emirates, Bulgaria, Chile, Czechia
-
Janssen Pharmaceutical K.K.RecruitingTreatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Taiwan, Korea, Republic of, Japan
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
AN2 Therapeutics, IncActive, not recruitingMAC Lung Disease | Treatment Refractory MAC Lung DiseaseUnited States, Australia, Japan, Korea, Republic of